Neurocrine Biosciences, Inc. Insider Transactions
Purchase
Sell
Neurocrine Biosciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 955 @ $116.79 | $111.54 K | 2,854 | 02/13/2025 | 02/14/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 1,056 @ $116.71 | $123.25 K | 44,689 | 02/13/2025 | 02/14/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 604 @ $116.74 | $70.51 K | 34,768 | 02/13/2025 | 02/14/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 700 @ $118.31 | $82.82 K | 1,998 | 02/10/2025 | 02/12/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 700 @ $118.28 | $82.79 K | 18,831 | 02/10/2025 | 02/12/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 980 @ $118.22 | $115.85 K | 33,253 | 02/10/2025 | 02/12/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 2,274 @ $118.37 | $269.17 K | 519,074 | 02/10/2025 | 02/12/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 980 @ $118.31 | $115.94 K | 42,799 | 02/10/2025 | 02/12/2025 | |
|
Lippoldt Darin
Chief Legal Officer |
Sell | 911 @ $118.25 | $107.73 K | 41,679 | 02/10/2025 | 02/12/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 980 @ $118.27 | $115.91 K | 33,561 | 02/10/2025 | 02/12/2025 | |
|
Gano Kyle
CEO |
Sell | 980 @ $118.39 | $116.02 K | 137,658 | 02/10/2025 | 02/12/2025 | |
|
Delaet Ingrid
Chief Regulatory Officer |
Sell | 623 @ $149.29 | $93.01 K | 3,442 | 02/03/2025 | 02/04/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 1,104 @ $152.94 | $168.85 K | 1,369 | 01/31/2025 | 02/04/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 824 @ $152.89 | $125.98 K | 18,202 | 01/31/2025 | 02/04/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 1,207 @ $152.94 | $184.60 K | 41,919 | 01/31/2025 | 02/04/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 1,283 @ $152.87 | $196.14 K | 32,681 | 01/31/2025 | 02/04/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 2,707 @ $152.92 | $413.97 K | 517,030 | 01/31/2025 | 02/04/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 1,457 @ $152.80 | $222.64 K | 32,373 | 01/31/2025 | 02/04/2025 | |
|
Onyia Jude
Chief Scientific Officer |
Sell | 126 @ $152.97 | $19.27 K | 15,561 | 01/31/2025 | 02/04/2025 | |
|
Lippoldt Darin
Chief Legal Officer |
Sell | 1,250 @ $152.91 | $191.13 K | 40,863 | 01/31/2025 | 02/04/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. FAQ's
The list of insiders at Neurocrine Biosciences, Inc. includes Delaet Ingrid, Gano Kyle, GORMAN KEVIN CHARLES, Cooke Julie, ROBERTS EIRY, Onyia Jude, Lippoldt Darin, Boyer David W., BENEVICH ERIC, ABERNETHY MATT, SHERWIN STEPHEN A, RASTETTER WILLIAM H.
Insiders have sold a total of 303.47 K Neurocrine Biosciences, Inc. shares in the last 12 months for a total of 42.14 M sold.
The following insiders have sold Neurocrine Biosciences, Inc. shares in the last 12 months: Delaet Ingrid ($514.12 K), Gano Kyle ($9.85 M), GORMAN KEVIN CHARLES ($23.20 M), Cooke Julie ($529.95 K), ROBERTS EIRY ($596.75 K), Onyia Jude ($355.51 K), Lippoldt Darin ($553.85 K), Boyer David W. ($460.06 K), BENEVICH ERIC ($551.97 K), ABERNETHY MATT ($610.97 K), SHERWIN STEPHEN A ($1.61 M), RASTETTER WILLIAM H ($3.31 M),
The list of congress members trading at Neurocrine Biosciences, Inc. includes Michael McCaul.